PharmaCyte Biotech, Inc.: Form 8-K, filed May 11, 2023
Filed with the SEC on May 11, 2023 and accepted by EDGAR at May 11, 2023, 12:30 ET.
Items reported
- Item 1.01 Entry into a material agreement
- Item 3.02 Unregistered sale of equity
- Item 5.03 Amendment to articles or bylaws
- Item 5.07 Shareholder vote results
- Item 8.01 Other events
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001683168-23-003169. Last ingested by Listed: Oct 24, 2026, 15:05 ET. Listed shows no prices and gives no investment advice.